Just FYI everyone, for those near Utah, Doug Sborov is opening trial spots. While they have Abecma and Carvykti spots, he also said that they just opened two more CAR T clinical trials at Huntsman which include LUMMICAR-2 (a new CAR T called Zevor-cel by CARSgen Therapeutics), a BCMA CAR T. The second one is ARC-112A (a new CAR T called CARddbmca) by Arcellx. Interestingly, Arcellx was just bought by Kite Pharma which is a CAR T only company and has products in leukemia and lymphoma. They say they've nailed the production issues and have much faster production than others.